1. Home
  2. LMAT vs BHVN Comparison

LMAT vs BHVN Comparison

Compare LMAT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • BHVN
  • Stock Information
  • Founded
  • LMAT 1983
  • BHVN 2013
  • Country
  • LMAT United States
  • BHVN United States
  • Employees
  • LMAT N/A
  • BHVN N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LMAT Health Care
  • BHVN Health Care
  • Exchange
  • LMAT Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • LMAT 1.9B
  • BHVN 1.9B
  • IPO Year
  • LMAT 2006
  • BHVN 2017
  • Fundamental
  • Price
  • LMAT $84.09
  • BHVN $14.18
  • Analyst Decision
  • LMAT Buy
  • BHVN Strong Buy
  • Analyst Count
  • LMAT 6
  • BHVN 14
  • Target Price
  • LMAT $100.80
  • BHVN $58.85
  • AVG Volume (30 Days)
  • LMAT 148.7K
  • BHVN 1.8M
  • Earning Date
  • LMAT 08-05-2025
  • BHVN 08-07-2025
  • Dividend Yield
  • LMAT 0.95%
  • BHVN N/A
  • EPS Growth
  • LMAT 30.45
  • BHVN N/A
  • EPS
  • LMAT 1.97
  • BHVN N/A
  • Revenue
  • LMAT $226,256,000.00
  • BHVN N/A
  • Revenue This Year
  • LMAT $13.88
  • BHVN $3.00
  • Revenue Next Year
  • LMAT $8.81
  • BHVN $59.97
  • P/E Ratio
  • LMAT $42.90
  • BHVN N/A
  • Revenue Growth
  • LMAT 13.19
  • BHVN N/A
  • 52 Week Low
  • LMAT $71.42
  • BHVN $13.69
  • 52 Week High
  • LMAT $109.58
  • BHVN $55.70
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 52.33
  • BHVN 42.97
  • Support Level
  • LMAT $82.77
  • BHVN $13.75
  • Resistance Level
  • LMAT $86.94
  • BHVN $15.09
  • Average True Range (ATR)
  • LMAT 2.03
  • BHVN 0.72
  • MACD
  • LMAT 0.13
  • BHVN 0.13
  • Stochastic Oscillator
  • LMAT 53.12
  • BHVN 32.89

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: